Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Dakin's solution for radiation dermatitis in head and neck cancer
NCT02369835Phase 3Completed
- Sponsor
- Stanford University
- Start
- May 2015
- Primary completion
- Jul 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium hypochlorite in radiation-induced dermatitis (RID), sponsored by Stanford University. Started May 2015; status: completed.
02
Drugs
sodium hypochlorite
03
Conditions
radiation-induced dermatitis (RID)
Beyond the preview
Go deeper on NCT02369835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369835.